PharmaSmart International, Inc.

PharmaSmart International, Inc. is a US-based company specializing in clinically-validated blood pressure kiosks that enhance health monitoring. Their innovative solutions cater to healthcare facilities, pharmacies, and fitness clubs, facilitating effective blood pressure management. PharmaSmart International, Inc.

develops health monitoring solutions focused on blood pressure management. The company is headquartered in Rochester, US. They have engaged in one significant funding round on July 12, 2021, with CPS Capital Partners and management investing in the company. Details of previous pivots or changes in strategy are not available.

PharmaSmart specializes in clinically-validated blood pressure kiosks designed to enhance health monitoring and management. Their core product offerings include the PS-2000D, PS-2000C, and PS-1000 models, which facilitate the measurement of blood pressure, weight, and pulse rate, while also calculating Body Mass Index (BMI). These kiosks utilize patented cuff technology and digital health tracking systems to provide users with the ability to monitor their blood pressure history confidentially online. The primary end-users of these kiosks are individuals in healthcare facilities, pharmacies, community health resources, and fitness clubs, as well as patients seeking to manage their blood pressure effectively.

PharmaSmart has a significant presence in North America, with potential expansions into markets across Europe and other regions, catering to an estimated 1. 13 billion people affected by hypertension globally. PharmaSmart's revenue generation model is structured around B2B transactions, partnering primarily with pharmacies, medical and ambulatory care facilities, as well as health and fitness clubs. The company provides its flagship products, including the PS-2000D and PS-1000, through direct sales to these entities, which in turn offer services to their customers.

Transactions typically involve upfront purchases of the kiosks and potential recurring revenue from service agreements related to maintenance and software updates. Pricing plans are dependent on the specific model and features selected by the clients, allowing for tailored solutions that meet the needs of various healthcare providers. Furthermore, PharmaSmart supports its clientele through programs that enhance patient health tracking and engagement, thereby facilitating ongoing relationships and customer loyalty. PharmaSmart International, Inc.

aims to expand its footprint and product services across North America, leveraging the investment received in July 2021 from CPS Capital Partners and management. The company is focused on enhancing its product offerings, with potential new launches in the pipeline, though specific details about upcoming products have not been disclosed. The investment will primarily support these expansion efforts and help to strengthen their presence in existing and new markets.